Literature DB >> 17054459

Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients.

Giovanni Targher1, Lorenzo Bertolini, Roberto Padovani, Luciano Zenari, Luca Scala, Massimo Cigolini, Guido Arcaro.   

Abstract

OBJECTIVE: To estimate the prevalence of hypovitaminosis D among type 2 diabetic adults and to assess the relationship between hypovitaminosis D and intimal medial thickening (IMT) of the common carotid artery, a marker of preclinical atherosclerosis. DESIGN, PATIENTS AND MEASUREMENTS: We compared winter serum 25-hydroxyvitamin D3 [25(OH)D] concentrations in 390 consecutive type 2 diabetic patients and 390 nondiabetic controls who were comparable for age and sex. Common carotid IMT was measured with ultrasonography only in diabetic patients by a single trained operator blinded to subjects' details.
RESULTS: The prevalence of hypovitaminosis D (i.e. 25(OH)D <or= 37.5 nmol/l) was higher in diabetic patients (34.0 vs 16.4%, P < 0.001) than in controls. Among diabetic patients, those with hypovitaminosis D (n = 130) had a marked increase in common carotid IMT (1.10 +/- 0.15 vs 0.87 +/- 0.14 mm, P < 0.001) when compared with their vitamin d-sufficient counterparts (n = 260). These patients also had significantly higher haemoglobin A1c, fibrinogen and C-reactive protein (hs-CRP) concentrations. In multivariate regression analysis, low 25(OH)D concentrations independently predicted carotid IMT (P < 0.001) in people with type 2 diabetes after adjustment for classical risk factors, diabetes duration, HbA1c, calcium, renal function tests, inflammatory markers, use of medications, and presence of the metabolic syndrome (as defined by the Adult Treatment Panel III criteria).
CONCLUSIONS: Hypovitaminosis D is highly prevalent in type 2 diabetic adults and is strongly and independently associated with increased carotid IMT. Further investigation into whether vitamin D may play a role in the prevention of atherosclerosis appears to be warranted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17054459     DOI: 10.1111/j.1365-2265.2006.02633.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  78 in total

Review 1.  Does vitamin D affect risk of developing autoimmune disease?: a systematic review.

Authors:  Martin A Kriegel; JoAnn E Manson; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2010-11-02       Impact factor: 5.532

2.  Does vitamin D have any role in the improvement of diabetic peripheral neuropathy in type 1 diabetic patients?

Authors:  U Ozuguz; S Oruc; M S Ulu; H Demirbas; A Acay; B Coker; B Beyazıt; M Yaman; T Koken
Journal:  J Endocrinol Invest       Date:  2016-07-19       Impact factor: 4.256

3.  Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland.

Authors:  Jyrki K Virtanen; Tarja Nurmi; Sari Voutilainen; Jaakko Mursu; Tomi-Pekka Tuomainen
Journal:  Eur J Nutr       Date:  2010-10-26       Impact factor: 5.614

4.  Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes?

Authors:  Giovanna Muscogiuri; Vincenzo Nuzzo; Adriano Gatti; Alfonso Zuccoli; Silvia Savastano; Carolina Di Somma; Rosario Pivonello; Francesco Orio; Annamaria Colao
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

5.  The effects of vitamin D supplementation on proatherogenic inflammatory markers and carotid intima media thickness in subjects with metabolic syndrome: a randomized double-blind placebo-controlled clinical trial.

Authors:  Shabnam Salekzamani; Abolhassan Shakeri Bavil; Hossein Mehralizadeh; Mohammad Asghari Jafarabadi; Aymaral Ghezel; Bahram Pourghassem Gargari
Journal:  Endocrine       Date:  2017-05-16       Impact factor: 3.633

6.  Carotid intima-media thickness is not associated with vitamin D and PTH levels in patients admitted to an Internal Medicine Department.

Authors:  Vincenzo Carnevale; Rita Minonne; Angela De Matthaeis; Maria Antonietta Annese; Patrizia Tabacco; Palmina D'Arcangelo; Graziella D'Amico; Alfredo Scillitani
Journal:  Endocrine       Date:  2014-02-13       Impact factor: 3.633

7.  Serum 25-hydroxyvitamin d levels are not associated with subclinical vascular disease or C-reactive protein in the old order amish.

Authors:  Erin D Michos; Elizabeth A Streeten; Kathleen A Ryan; Evadnie Rampersaud; Patricia A Peyser; Lawrence F Bielak; Alan R Shuldiner; Braxton D Mitchell; Wendy Post
Journal:  Calcif Tissue Int       Date:  2009-01-16       Impact factor: 4.333

8.  25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification.

Authors:  Ian H de Boer; Bryan Kestenbaum; Abigail B Shoben; Erin D Michos; Mark J Sarnak; David S Siscovick
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

9.  25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958 British Birth Cohort.

Authors:  Elina Hyppönen; Diane Berry; Mario Cortina-Borja; Chris Power
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

10.  Does vitamin d deficiency cause hypertension? Current evidence from clinical studies and potential mechanisms.

Authors:  M Iftekhar Ullah; Gabriel I Uwaifo; William C Nicholas; Christian A Koch
Journal:  Int J Endocrinol       Date:  2009-11-10       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.